| Patents for C07D 473 - Heterocyclic compounds containing purine ring systems (11,932) |
|---|
| 03/01/2007 | US20070048752 Mass tags for quantitative analyses |
| 03/01/2007 | CA2620182A1 Tlr agonists |
| 02/28/2007 | EP1757606A1 Xanthinderivatives, preparation thereof and their use as medical agents |
| 02/28/2007 | EP1757289A1 Composition for acceleration of alcohol metabolism or recuperation from fatigue through gluconeogenesis |
| 02/28/2007 | EP1756120A1 Purine derivative |
| 02/28/2007 | EP1456209B1 A2a adenosine receptor antagonists |
| 02/28/2007 | CN1922179A Crystalline forms of valacyclovir hydrochloride |
| 02/28/2007 | CN1922155A Novel sulfone amide derivative |
| 02/28/2007 | CN1302116C Preparation method of antipode of (1R, 4S)-or (1S, 4R)-1-amino-4-(methylol)-2-cyclopentene derivative |
| 02/27/2007 | US7183280 Bicyclic imidazole derivatives, the preparation thereof and their use as pharmaceutical compositions |
| 02/27/2007 | US7183268 2-amino-9-[(2-hydroxymethyl) cyclopropylidenemethyl] purine antiviral agents |
| 02/22/2007 | WO2006130736A3 High quantum yield acridinium compounds and their uses in improving assay sensitivity |
| 02/22/2007 | WO2006127217A3 Cyclopropanecarboxylate esters of acyclovir |
| 02/22/2007 | WO2006091898A3 Pyrazolyl substituted xanthines |
| 02/22/2007 | WO2006091897A3 Derivatives of 8-substituted xanthines |
| 02/22/2007 | WO2006091896A3 Pyridyl substituted xanthines |
| 02/22/2007 | US20070043048 Such as 2-methyl-4-{5-[2-(2,2,6,6-tetramethyl-piperidin-4-ylamino)-pyrimidin-4-yl]-thiophen-2-yl}-butan-2-ol; tumor necrosis factor inhibitors; immunosuppressants; antiinflammatory agents |
| 02/22/2007 | CA2618513A1 Unsaturated heterocyclic derivatives |
| 02/21/2007 | EP1754710A2 2'-Fluoroncucleosides |
| 02/21/2007 | EP1529047B1 New purine derivatives |
| 02/21/2007 | EP1355905B1 Pyrazole compounds useful as protein kinase inhibitors |
| 02/21/2007 | CN1301252C Production method of high purity tea polyphenol and caffeine |
| 02/20/2007 | US7179922 Chemical compounds |
| 02/20/2007 | US7179896 Method of making PNA oligomers |
| 02/20/2007 | US7179794 Antibiotics; bactericides |
| 02/20/2007 | CA2335520C Adenosine derivatives |
| 02/15/2007 | WO2007017265A1 Xanthine derivatives as selective hm74a agonists |
| 02/15/2007 | WO2007017262A1 Xanthine derivatives as selective hm74a agonists |
| 02/15/2007 | WO2007017261A1 Xanthine derivatives as selective hm74a agonists |
| 02/15/2007 | WO2007017083A1 Pyrazole derivatives having tyrosinkinase activity |
| 02/15/2007 | WO2007017069A1 Adenine derivatives |
| 02/15/2007 | US20070037977 Substituted-1, 3-oxathiolanes and substituted-1, 3-dioxolanes with antiviral properties |
| 02/15/2007 | US20070037975 Substituted-1,3-oxathiolanes and substituted-1, 3-dioxolanes with antiviral properties |
| 02/15/2007 | US20070037832 2-butylamino-8-hydroxy-9-(6-methyl-3-pyridylmethyl)adenine; interferon inducing activity; antiviral, antiallergic agent; immune response modulator; hepatitis B and C, asthma, atopic dermatitis |
| 02/15/2007 | DE102005037733A1 Adeninderivate Adenine derivatives |
| 02/15/2007 | DE102005037499A1 Pyrazolderivate Pyrazole derivatives |
| 02/15/2007 | CA2626723A1 Xanthine derivatives as selective hm74a agonists |
| 02/15/2007 | CA2618963A1 Xanthine derivatives as selective hm74a agonists |
| 02/15/2007 | CA2618633A1 Adenine derivatives |
| 02/15/2007 | CA2618524A1 Pyrazole derivatives having tyrosine kinase activity |
| 02/14/2007 | EP1751159A2 Purine derivatives as a1 adenosine receptor antagonists |
| 02/14/2007 | EP1751158A1 Process for the preparation of entecavir and novel intermediates thereof via carbon-silicon oxidation |
| 02/14/2007 | EP1368349B1 Xanthine derivative, production and use thereof as a medicament |
| 02/14/2007 | EP1345928B1 Pyrazole compounds useful as protein kinase inhibitors |
| 02/14/2007 | CN1911931A Pyridine and pyrimidine derivatives and their use as inhibitors of cytokine mediated disease |
| 02/13/2007 | US7176312 Kinase inhibitor scaffolds and methods for their preparation |
| 02/13/2007 | US7176242 N,N′-substituted-1,3-diamino-2-hydroxypropane derivatives |
| 02/08/2007 | WO2007014886A1 Hydrochlorides and hydrates of 1-[(3-cyanopyridin-2-yl)methyl]-3-methyl-7-(2-butyn-1-yl)-8-(3-aminopiperidin-1-yl)xanthine, their preparation and their use as medicaments |
| 02/08/2007 | US20070032640 Cytokine receptor |
| 02/08/2007 | US20070032468 Novel thioxanthine derivatives for use as inhibitors of mpo |
| 02/08/2007 | DE102005035891A1 8-(3-Amino-piperidin-1-yl)-xanthine, deren Herstellung und deren Verwendung als Arzneimittel 8- (3-amino-piperidin-1-yl) -xanthines, their preparation and their use as medicaments |
| 02/08/2007 | CA2617090A1 Hydrochlorides and hydrates of 1-[(3-cyano-pyridin-2-yl)methyl]-3-methy l-7-(2-butyn-1-yl)-8-(3-amino-piperidin-1-yl)xanthine,their preparation and their use as medicaments |
| 02/07/2007 | EP1230241B1 Adenosine receptor antagonists and methods of making and using the same |
| 02/07/2007 | CN1910184A Process for the preparation of valacyclovir hydrochloride |
| 02/07/2007 | CN1907987A Entecavir acid addition salt, preparation method and use thereof |
| 02/07/2007 | CN1298719C Purine derivatives, preparation method and pharmaceutical compositions containing same |
| 02/07/2007 | CN1298707C Imidazole and benzimiddzole caspase inhibitors and uses thereof |
| 02/06/2007 | US7173031 Pyrrolotriazine kinase inhibitors |
| 02/01/2007 | WO2007013645A1 Valacyclovir precursor, valacyclovir and salts thereof, and process for the production of them |
| 02/01/2007 | WO2007013086A1 Novel polymorphs of tenofovir disoproxil fumarate |
| 02/01/2007 | WO2007013085A1 Novel process for acyclic phosphonate nucleotide analogs |
| 02/01/2007 | WO2006086609A3 Inhibitors of tryptase |
| 02/01/2007 | US20070027316 Process for the preparation of (1s, 4r)-cis-4-'2-amino-6chloro-9h-purin-yl!-2-cyclopentene-1- methanol |
| 02/01/2007 | US20070027310 Novel ligands and methods for preparing same |
| 02/01/2007 | US20070027168 8-(3-amino-piperidin-1-yl)-xanthines, their preparation, and their use as pharmaceuticals |
| 02/01/2007 | US20070027151 A bi-heterocyclic compound e.g 3-methoxyphenyl)-{6-Morpholin-4-yl-2-[2-(pyridin-2-yloxy)-ethoxy]-9H-purin-8-yl}-amine or other derivatives useful for treating an interleukin-12 overproduction-related disorder such as rheumatoid arthritis, sepsis, Crohn's disease, multiple sclerosis, psoriasis or diabetes |
| 01/31/2007 | EP1747223A1 Drying process for preparing crystalline solid famciclovir |
| 01/31/2007 | CN1906196A 4'-substituted carbovir-and abacavir-derivatives as well as related compounds with HIV and HCV antiviral activity |
| 01/31/2007 | CN1903854A Method of synthesizing valaciclovir hydrochloride |
| 01/30/2007 | US7169766 Administering nucleoside, or prodrug thereof; viricides |
| 01/25/2007 | WO2006084030A3 Small-molecule hsp90 inhibitors |
| 01/25/2007 | US20070021444 Valacyclovir polymorphs and a process for the preparation thereof |
| 01/25/2007 | US20070021443 Purine and imidazopyridine derivatives for immunosuppression |
| 01/25/2007 | US20070020672 Nucleic acid melting analysis with saturation dyes |
| 01/24/2007 | EP1746098A1 Valacyclovir polymorphs and a process for the preparation thereof |
| 01/24/2007 | EP1746096A1 2-Arylbenzothiazole analogues and uses thereof in the treatment of cancer |
| 01/24/2007 | CN1902201A Bicyclic pyrimidin-4-(3H)-ones and analogues and derivatives thereof which modulate the function of the vanilloid-1 receptor (VR1) |
| 01/24/2007 | CN1900078A Entecavir potassium salt compound and its preparing method and medicine use |
| 01/23/2007 | CA2289753C Carbocyclic nucleoside hemisulfate and its use in treating viral infections |
| 01/23/2007 | CA2239968C Pyrimidine derivatives and guanine derivatives, and their use in treating tumour cells |
| 01/18/2007 | US20070015732 Adenosine receptor antagonists and methods of making and using the same |
| 01/18/2007 | US20070015725 2-azapurine compounds and their uses |
| 01/17/2007 | EP1532148B1 Novel purine- or pyrrolol(2,3-d)pyrimidine-2-carbonitiles for treating diseases associated with cysteine protease activity |
| 01/17/2007 | CN1898243A Bicyclic heterocyclic p-38 kinase inhibitors |
| 01/17/2007 | CN1896077A Synthesis and purification of valacyclovir |
| 01/16/2007 | US7164027 Aralkyl ester soft drugs |
| 01/16/2007 | US7163928 Partial and full agonists of A1 adenosine receptors |
| 01/11/2007 | WO2007004688A1 Xanthine oxidase inhibitor |
| 01/11/2007 | WO2006120481A3 2,3-substituted fused bicyclic pyrimidin-4(3h)-ones which modulate the function of the vanilloid-1 receptor (vr1) |
| 01/11/2007 | WO2006079731A3 Use of cacao polyphenols for treating a prostate hyperplasia, a specific cacao extract and applications |
| 01/11/2007 | US20070010669 Novel class of cytodifferentiating agents and histone deacetylase inhibitors, and methods of use thereof |
| 01/11/2007 | US20070010535 Antagonists of the magnesium binding defect as therapeutic agents and methods for treatment of abnormal physiological atates |
| 01/10/2007 | EP1740587A2 Selective antagonists of a-2a- adenosine receptors |
| 01/10/2007 | EP1355916B1 Nucleoside derivatives as inhibitors of rna-dependent rna viral polymerase |
| 01/10/2007 | CN1894250A Substituted 8-heteroaryl xanthines |
| 01/10/2007 | CN1894234A 二肽基肽酶抑制剂 Dipeptidyl peptidase inhibitors |
| 01/10/2007 | CN1894190A Method for the production of tetrahydrogeranylacetone |
| 01/10/2007 | CN1891221A Combination therapy to treat hepatitis b virus |
| 01/09/2007 | US7160899 Use of at least one compound with neurotrophic activity and at least one adenosine A2A receptor antagonist for the manufacture of a medicament for the treatment, prevention or alleviation of Parkinson's disease in a subject |
| 01/09/2007 | US7160872 Methods to treat conditions mediated by chemokine receptors |